riksag Profile Banner
Sagnik Sen, M.D. Profile
Sagnik Sen, M.D.

@riksag

Followers
546
Following
6K
Media
176
Statuses
2K

Retina-Uvea-Genetics | #Vitreoretina surgeon @gsttNHS @Moorfields | #MAMC @aiims_newdelhi @aravind_eyecare | #KVPYFellow| l๐Ÿ‡ฎ๐Ÿ‡ณ๐Ÿ‡ฌ๐Ÿ‡ง

๐Ÿ“Kolkata-Delhi-Madurai-London
Joined July 2009
Don't wanna be here? Send us removal request.
@riksag
Sagnik Sen, M.D.
3 years
First of a kind deep-learning model for predicting the gene in Inherited Retinal Diseases from retinal imaging! Grateful to be a part of this amazing collaboration @UCLeye and @Moorfields ! @npontikos @william_woof .@tacguimaraes @MichelMichaelid @KonBalaskas #deeplearning #gene.
@Eye2Gene
Eye2Gene
3 years
Our preprint.
1
2
14
@riksag
Sagnik Sen, M.D.
18 days
RT @NEIDirector: Next-generation phenotyping of inherited retinal diseases: Eye2Gene (AI-driven algorithm). Better-than-expert accuracy forโ€ฆ.
0
13
0
@riksag
Sagnik Sen, M.D.
1 month
RT @SamanthaTaghoy: I suffered with an eating disorder through my teenage years. When I was 15, I spent over a month in hospital refusingโ€ฆ.
0
988
0
@riksag
Sagnik Sen, M.D.
3 months
๐ŸŽ“Curious about the research behind the numbers?.Check out my Google Scholar profile here: Hereโ€™s to the next chapter of inquiry, innovation, and impact!. #AcademicLife #Research #Scholarship #GoogleScholar #Gratitude #Milestone #1000Citations.
Tweet card summary image
scholar.google.com
Senior Clinical fellow, Vitreoretina, St Thomas' Hospital, Research Fellow, Moorfields & UCL - Cited by 1,104 - Vitreoretinal surgery - Anti-VEGF - Vascular diseases - Uveitis - Artificial Intellig...
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
This milestone reflects not just my journey, but the collaborations, mentorship, and ongoing curiosity that drive #academicresearch forward. Thank you to all colleagues, co-authors, and the research community for the continued engagement and support.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
Milestone Achieved: 1,000 #Citations!.๐ŸŽ‰๐Ÿ™Œ๐ŸŽ๐ŸŽŠ๐ŸŽˆ๐ŸŽ†๐ŸŽ“. Iโ€™m humbled and honoured to share that my work has now been cited over 1,000 times on #GoogleScholar.
Tweet media one
4
0
1
@riksag
Sagnik Sen, M.D.
3 months
7/7.๐Ÿ“ Sen et al. โ€“ โ€œRisk factors and incidence of macular edema in eyes with RVO after cataract surgeryโ€.๐Ÿ“… Published: April 2025.๐Ÿ“– Read: Thank you to my amazing team for bringing this to life!.#MEVOstudy #OphthalmologyResearch.
0
0
0
@riksag
Sagnik Sen, M.D.
3 months
6/7.๐Ÿ‘๏ธโ€๐Ÿ—จ๏ธ Clinical Insight:.Cataract surgery in RVO eyes needs extra care and tailored counseling. Even without pre-op edema, risk of PME lingers, especially with systemic conditions like diabetes. #OphthoTwitter #RetinaTips.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
5/7.๐Ÿ“‰ Visual Outcomes:.Significant VA improvement overall. But PME, CRVO, or poor baseline VA (<6/12) โ†’ poorer final vision.โš ๏ธ CRVO eyes fared worse than BRVO.#VisualAcuity #CRVO.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
4/7.๐Ÿ•’ Timing:.60% of PME occurred within 1 month post-op. ๐Ÿ”Ž We recommend routine OCT screening at the first follow-up after cataract surgery in RVO patients. #EarlyDetection #CataractSurgery.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
3/7.๐Ÿ’ก Key risk factors:.Diabetes (OR = 2.1). History of CME (OR = 4.62). Anti-VEGF treatment (OR = 4.83).๐Ÿ“Œ mSICS increased risk in diabetics + hypertensives (OR = 5.86).#RetinalCare #EyeSurgery.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
2/7.๐Ÿ“Š Incidence of PME:.Overall: 40.1%. With previous CME: 57.3%. In diabetics: 50%. With CRVO: 48.8%.Even โ€œuneventfulโ€ cataract surgeries carry significant risk in RVO eyes. #MacularEdema #Retina.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
๐Ÿงต 1/7.๐Ÿšจ Proud to share our latest research published in Indian Journal of Ophthalmology!.Our team led the MEVO study, exploring the risk of Postoperative Macular Edema (PME) in eyes with Retinal Vein Occlusion (RVO) after cataract surgery. Key findings ahead ๐Ÿ‘‡.#MEVOstudy
Tweet media one
2
0
2
@riksag
Sagnik Sen, M.D.
3 months
Some more reading materials on this topic:. Exciting times ahead!!!๐Ÿ˜ƒ ๐Ÿ˜ƒ ๐Ÿ˜ƒ.
Tweet card summary image
science.org
Retinol binding protein 3 may protect against the progression of diabetic retinopathy by inhibiting glucose uptake into retinal cells.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
๐Ÿงช Methodology included:.- #Massspectrometry of vitreous SEVs.- #Immunoblotting and #ELISA validations.- Plasma SEV profiling in patients across DR stages. ๐Ÿ“š Read the full study:
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
This is a major step towards developing multi-analyte #biomarker panels for early and accurate #DR screening and paves the way for future therapeutic innovations like RBP3 supplementation.
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
Until now, its presence in circulation was hard to detect, limiting its use as a #biomarker. Our findings show that circulatory SEVs can carry retinal biomarkers, opening up non-invasive diagnostic possibilities for vision-threatening diabetic retinopathy.
Tweet media one
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
Most notably, we discovered a significant reduction of RBP3 levels in patients with proliferative DR (PDR). ๐Ÿ’ก Why this matters:.RBP3, a photoreceptor-derived protein, has been known for its protective role in retinal health.
Tweet media one
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
๐Ÿ‘ฉโ€๐Ÿ”ฌ From the teams at Aravind Medical Research Foundation & Aravind Eye Hospital.In a first-of-its-kind study, we identified Retinol-binding protein 3 (RBP3) in small #extracellularvesicles (SEVs) from both the #vitreoushumor and plasma of patients with #diabeticretinopathy (DR).
1
0
0
@riksag
Sagnik Sen, M.D.
3 months
๐Ÿšจ New Research Alert!. Proud to share our latest work published in #ExperimentalEyeResearch ๐Ÿš€. ๐Ÿ“Œ Title: Retinol-binding protein 3 in vitreous and plasma-derived small extracellular vesicles is reduced in proliferative diabetic retinopathy
Tweet media one
1
0
0